ACTA2 and MSMDS
Mutations in the ACTA2 gene are the most common cause of Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS).
Certain variants, particularly those affecting the arginine 179 (Arg179) position, are strongly associated with the most severe and early-onset forms of the condition.
Other variants, such as those affecting Arg258, as well as mutations in related genes like MYH11, have also been linked to MSMDS.
How these ACTA2 mutations affect the body
ACTA2 plays a key role in the function of smooth muscle throughout the body.
When this gene is altered, smooth muscle cells cannot function properly, affecting multiple organ systems from birth.
This disruption explains why MSMDS presents as a multisystem condition rather than a single-organ disease.
Clinical features associated with ACTA2-related MSMDS
These genetic changes can lead to a wide range of clinical manifestations, including:
- Congenital mydriasis (dilated pupils from birth)
- Congenital heart defects (such as Patent Ductus Arteriosus -PDA- or Aortopulmonary Window -APW-)
- Cerebrovascular disease, including stroke
- Aortic aneurysms and dissections
- Lung, gastrointestinal, and bladder involvement
Because many of these features can be present early in life, ACTA2-related MSMDS may be identifiable from birth through clinical evaluation and confirmed with genetic testing.
